Acadia Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
ALKERMES USD 1.8M 35K 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Corcept Therapeutics USD 136K 1000 2024-12
Cytokinetics USD 118K 0 2024-12
Eisai JPY 44.99B 0 2024-12
Eli Lilly USD 592.6M 200K 2025-03
Incyte USD 193K 0 2025-03
J&J USD 3.12B 0 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Pfizer USD 481M 1000K 2025-03
Prothena USD 538K 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Sarepta Therapeutics USD 10K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Acadia Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.